BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21530386)

  • 1. False-negative serology in patients with acute parvovirus B19 infection.
    Bredl S; Plentz A; Wenzel JJ; Pfister H; Möst J; Modrow S
    J Clin Virol; 2011 Jun; 51(2):115-20. PubMed ID: 21530386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
    Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
    J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI; Enders M; Motz M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
    Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
    J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic tests: Human parvovirus B19].
    Nunoue T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():329-31. PubMed ID: 16111265
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
    Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
    Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
    Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
    J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parvovirus B19 in cord blood of premature infants.
    Koga M; Matsuoka T; Katayama K; Takeda K; Nakata M; Sase M; Kato H; Furukawa S
    Am J Perinatol; 2001 Aug; 18(5):237-40. PubMed ID: 11552176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection.
    Kok RH; Wolfhagen MJ; Klosters G
    Clin Infect Dis; 2001 Jan; 32(2):311-2. PubMed ID: 11170925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
    Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
    J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
    Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
    Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
    Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
    J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
    Weseslindtner L; Aberle JH; Hedman L; Hedman K
    J Infect Dis; 2017 Jan; 215(2):214-220. PubMed ID: 27789725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum.
    Dieck D; Schild RL; Hansmann M; Eis-Hübinger AM
    Prenat Diagn; 1999 Dec; 19(12):1119-23. PubMed ID: 10590428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parvovirus B19 infection: diagnosing and treating a kidney transplant patient].
    León LR; Curcio D; Casadei D
    Nefrologia; 2010; 30(6):704. PubMed ID: 21113225
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
    Braham S; Gandhi J; Beard S; Cohen B
    J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological study of parvovirus B19 infection in women with recurrent spontaneous abortions.
    Kishore J; Gupta I
    Indian J Pathol Microbiol; 2006 Oct; 49(4):548-50. PubMed ID: 17183849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.